Works by Correia-Melo, Fernanda S.

Results: 7
    1

    Brain-derived neurotrophic factor serum levels following ketamine and esketamine intervention for treatment-resistant depression: secondary analysis from a randomized trial.

    Published in:
    Trends in Psychiatry & Psychotherapy, 2023, v. 45, p. 1, doi. 10.47626/2237-6089-2021-0298
    By:
    • Caliman-Fontes, Ana Teresa;
    • Leal, Gustavo C.;
    • Correia-Melo, Fernanda S.;
    • Paixao, Camilla S.;
    • Carvalho, Michelle S.;
    • Jesus-Nunes, Ana Paula;
    • Vieira, Flavia;
    • Magnavita, Guilherme;
    • Bandeira, Igor D.;
    • Mello, Rodrigo P.;
    • Beanes, Graziele;
    • Silva, Samantha S.;
    • Echegaray, Mariana;
    • Carvalho, Lucas P.;
    • Machado, Paulo;
    • Sampaio, Aline S.;
    • Cardoso, Taiane de A.;
    • Kapczinski, Flávio;
    • Lacerda, Acioly L. T.;
    • Quarantini, Lucas C.
    Publication type:
    Article
    2
    3
    4

    Suicide attempt, impulsivity, and exposure to trauma in college students.

    Published in:
    Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria, 2022, v. 44, n. 3, p. 279, doi. 10.1590/1516-4446-2021-2175
    By:
    • Lira, Sidnei B.;
    • Vieira, Flávia;
    • Cavalcanti, Diogo E.;
    • Souza-Marques, Breno;
    • Netto, Liana R.;
    • Correia-Melo, Fernanda S.;
    • Leal, Gustavo C.;
    • Pereira, Juliana L.;
    • Santos, Lene L.;
    • Guedes, Gisela M.;
    • Teles, Carlos A.;
    • Cardoso, Taiane de A.;
    • Miranda-Scippa, Ângela;
    • Kapczinski, Flavio;
    • Lacerda, Acioly L. T.;
    • Koenen, Karestan C.;
    • Turecki, Gustavo;
    • Quarantini, Lucas C.
    Publication type:
    Article
    5
    6

    Clinical predictors of depressive symptom remission and response after racemic ketamine and esketamine infusion in treatment‐resistant depression.

    Published in:
    Human Psychopharmacology: Clinical & Experimental, 2022, v. 37, n. 4, p. 1, doi. 10.1002/hup.2836
    By:
    • Jesus‐Nunes, Ana Paula;
    • Leal, Gustavo C.;
    • Correia‐Melo, Fernanda S.;
    • Vieira, Flávia;
    • Mello, Rodrigo P.;
    • Caliman‐Fontes, Ana Teresa;
    • Echegaray, Mariana V. F.;
    • Marback, Roberta F.;
    • Guerreiro‐Costa, Lívia N. F.;
    • Souza‐Marques, Breno;
    • Santos‐Lima, Cassio;
    • Souza, Lucca S.;
    • Bandeira, Igor D.;
    • Kapczinski, Flavio;
    • Lacerda, Acioly L. T.;
    • Quarantini, Lucas C.
    Publication type:
    Article
    7

    Intravenous arketamine for treatment-resistant depression: open-label pilot study.

    Published in:
    European Archives of Psychiatry & Clinical Neuroscience, 2021, v. 271, n. 3, p. 577, doi. 10.1007/s00406-020-01110-5
    By:
    • Leal, Gustavo C.;
    • Bandeira, Igor D.;
    • Correia-Melo, Fernanda S.;
    • Telles, Manuela;
    • Mello, Rodrigo P.;
    • Vieira, Flavia;
    • Lima, Cassio S.;
    • Jesus-Nunes, Ana Paula;
    • Guerreiro-Costa, Lívia N. F.;
    • Marback, Roberta F.;
    • Caliman-Fontes, Ana Teresa;
    • Marques, Breno L. S.;
    • Bezerra, Marília L. O.;
    • Dias-Neto, Alberto L.;
    • Silva, Samantha S.;
    • Sampaio, Aline S.;
    • Sanacora, Gerard;
    • Turecki, Gustavo;
    • Loo, Colleen;
    • Lacerda, Acioly L. T.
    Publication type:
    Article